Literature DB >> 11483701

Ca(2+) influx in the endothelial cells is required for the bradykinin-induced endothelium-dependent contraction in the porcine interlobar renal artery.

E Ihara1, D N Derkach, K Hirano, J Nishimura, H Nawata, H Kanaide.   

Abstract

1. To determine the mechanism of bradykinin-induced production of endothelium-derived contracting factors, we monitored the changes in cytosolic Ca(2+) concentration ([Ca(2+)](i)) in in situ endothelial cells in porcine aortic valvular strips and the changes in [Ca(2+)](i) of smooth muscle cells and force in porcine interlobar renal arterial strips using front-surface fluorometry of fura-2. 2. In the presence of N(omega)-nitro-L-arginine methyl ester, bradykinin caused an endothelium-dependent transient elevation of [Ca(2+)](i) and contraction in smooth muscle in the interlobar renal artery. This contraction was completely inhibited by a prostaglandin H(2)/thromboxane A(2) receptor antagonist. 3. In the absence of extracellular Ca(2+), bradykinin failed to induce contraction. However, replenishing extracellular Ca(2+) to 0.75 mM and higher induced an instantaneous contraction. However, replenishing Ca(2+) per se did not induce any contraction in the absence of bradykinin. Pretreatment with either 10(-5) M 1-(beta-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenethyl)-1H-imidazole hydrochloride (SKF96365) or 0.2 mM Ni(2+) abolished the contraction induced by bradykinin in the presence of extracellular Ca(2+). 4. Treatment with 10(-5) M indomethacin completely inhibited the contractile response induced by Ca(2+) replenishment, regardless of the timing of its application, before or after the application of bradykinin. 5. In endothelial cells in the valvular strips, bradykinin caused a transient [Ca(2+)](i) elevation in the presence of 1.25 mM extracellular Ca(2+), but [Ca(2+)](i) returned to the resting level within 10 min. Neither 10(-5) M SKF96365 nor 0.2 mM Ni(2+) had any effect on the peak [Ca(2+)](i) elevation, but decreased [Ca(2+)](i) in the declining phase. In the absence of extracellular Ca(2+), bradykinin induced a transient [Ca(2+)](i) elevation to a level similar to that seen in the presence of 1.25 mM extracellular Ca(2+). However, [Ca(2+)](i) then rapidly returned to the prestimulation level within 5 min. Subsequent Ca(2+) replenishment to 0.75 mM and higher in the presence of bradykinin elevated [Ca(2+)](i) to significantly higher levels than the resting level seen in the media containing 1.25 mM Ca(2+). 6. In conclusion, Ca(2+) influx in the endothelial cells is essential for bradykinin to induce endothelium-dependent contraction in the porcine interlobar renal artery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483701      PMCID: PMC2278741          DOI: 10.1111/j.1469-7793.2001.t01-1-00701.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Agonist stimulation of B1 and B2 kinin receptors causes activation of the MAP kinase signaling pathway, resulting in the translocation of AP-1 in HEK 293 cells.

Authors:  H Naraba; A Ueno; Y Kosugi; M Yoshimura; M Murakami; I Kudo; S Oh-ishi
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

Review 3.  A reassessment of the low molecular weight phospholipase A2 gene family in mammals.

Authors:  J A Tischfield
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 4.  Function and inhibition of intracellular calcium-independent phospholipase A2.

Authors:  J Balsinde; E A Dennis
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

5.  Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells.

Authors:  A G Börsch-Haubold; F Bartoli; J Asselin; T Dudler; R M Kramer; R Apitz-Castro; S P Watson; M H Gelb
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

6.  Calcium-dependent phospholipase A2 mediates the production of endothelium-derived hyperpolarizing factor in perfused rat mesenteric prearteriolar bed.

Authors:  A S Adeagbo; M K Henzel
Journal:  J Vasc Res       Date:  1998 Jan-Feb       Impact factor: 1.934

Review 7.  Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2).

Authors:  R M Kramer; J D Sharp
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

8.  Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2.

Authors:  T Hirabayashi; K Kume; K Hirose; T Yokomizo; M Iino; H Itoh; T Shimizu
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

9.  Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery.

Authors:  J Kawasaki; K Hirano; J Nishimura; M Fujishima; H Kanaide
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

10.  Mechanism of endothelium-dependent relaxation induced by thrombin in the pig coronary artery.

Authors:  O Mizuno; K Hirano; J Nishimura; C Kubo; H Kanaide
Journal:  Eur J Pharmacol       Date:  1998-06-12       Impact factor: 4.432

View more
  3 in total

1.  Differential modulation of bradykinin-induced relaxation of endothelin-1 and phenylephrine contractions of rat aorta by antioxidants.

Authors:  Ogechukwu Anozie; Richonda Ross; Adebayo O Oyekan; Momoh A Yakubu
Journal:  Acta Pharmacol Sin       Date:  2007-10       Impact factor: 6.150

2.  Pharmacological analysis of the rat femoral artery response to bradykinin.

Authors:  Miroslav Radenković; Marko Stojanović; Nebojša Skorupan; Milica Prostran
Journal:  Sci Pharm       Date:  2013-06-04

3.  Vascular Tone Regulation Induced by C-Type Natriuretic Peptide: Differences in Endothelium-Dependent and -Independent Mechanisms Involved in Normotensive and Spontaneously Hypertensive Rats.

Authors:  Carolina Caniffi; Flavia M Cerniello; María N Gobetto; María L Sueiro; María A Costa; Cristina Arranz
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.